Vivek Agnihotri’s latest release The Vaccine War has taken a slow start. The film, which gives an insight into India’s remarkable victory in preparing the best vaccine to save the world from the hazardous COVID-19 pandemic, features Nana Patekar and Pallavi Joshi in lead roles.
According to a report in Sacnilk.com, The Vaccine War is expected to perform low on its first day at the box office. As per the early estimates, the film has managed to earn Rs 1.30 crore net on its day 1 in India.
Dubbed as ‘India’s first bio-science film’, The Vaccine War talks about the struggle of Indian scientists behind the development of Covid-19 vaccine. It also showcases Indian scientists working day and night in labs to find a cure for coronavirus.
News18 Showsha’s review of The Vaccine War reads: “Despite its important messaging, The Vaccine War lacks the nuance and hard-hitting quotient of Vivek Agnihotri’s previous films, The Taskent Files and The Kashmir Files. It’s a simple plot without any risky arcs and unpredictable storytelling. We understand that it’s no thriller and is a commentary on professionals who left no stone unturned to save multiple lives during the health crisis and put India’s medical progress on the global map but it lacks a certain cinematic spark. The narrative doesn’t carry enough weight to keep you hooked throughout its 2 hours 41 minutes runtime. But mind you, the pace isn’t really the problem here, the cramming of too many incidents is. The problem isn’t so much with what it’s trying to say but how it’s told thus giving it a very bland finish.”
Comments
0 comment